Substance misuse and early psychosis

Australasian Psychiatry

Volumn 17, Issue 4, 2009, Pages 291-294

  Tucker, Peter ^a  

^a SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

Author keywords

Amphetamines; Cannabis; Early psychosis; Schizophrenia; Substance misuse

Indexed keywords

ALCOHOL; CANNABIS; METHAMPHETAMINE;

ALCOHOL ABUSE; CANNABIS ADDICTION; CHRONIC DISEASE; COGNITIVE DEFECT; HUMAN; MENTAL DISEASE; POSITIVE SYNDROME; PREVALENCE; PSYCHOSIS; SCHIZOPHRENIA; SHORT SURVEY; SUBSTANCE ABUSE; ADDICTION; ADOLESCENT; ADULT; DRINKING BEHAVIOR; DRUG ABUSE; META ANALYSIS; ONSET AGE; PSYCHOLOGICAL ASPECT; REVIEW;

ADOLESCENT; ADULT; AGE OF ONSET; ALCOHOL DRINKING; AMPHETAMINE-RELATED DISORDERS; COGNITION DISORDERS; HUMANS; MARIJUANA ABUSE; METHAMPHETAMINE; PSYCHOSES, SUBSTANCE-INDUCED; PSYCHOTIC DISORDERS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 70249128716     PISSN: 10398562     EISSN: 14401665     Source Type: Journal    
DOI: 10.1080/10398560802657314     Document Type: Short Survey

References (40)

1. Hambrecht M, Hafner H. Substance abuse and the onset of schizophrenia. Biological Psychiatry 1996; 40: 1155-1163.
2. Cantwell R, Brewen J, Glazebrook C et al. Prevalence of substance misuse in first episode psychosis. British Journal of Psychiatry 1999; 174: 150-153.
3. Verdoux H, Liraud F, Gonzales B, Assens F, Abalan F, van Os J. Suicidality and substance misuse in first-admitted subjects with psychotic disorder. Acta Psychiatrica Scandinavica 1999; 100: 389-395.
4. Van Mastrigt S, Addington J, Addington D. Substance misuse at presentation to an early psychosis program. Social Psychiatry and Psychiatric Epidemiology 2004; 39: 69-72.
5. Addington J, Addington D. Patterns, predictors and impact of substance use in early psychosis: a longitudinal study. Acta Psychiatrica Scandinavica 2007; 115: 304-309.
6. Lambert M, Conus P, Lubman DI et al. The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatrica Scandinavica 2005; 112: 141-148.
7. Sim K, Swapna V, Mythily S et al. Psychiatric comorbidity in first-episode psychosis: the Early Psychosis Intervention Program (EPIP) experience. Acta Psychiatrica Scandinavica 2004; 109: 23-29.
8. Korkeila JA, Svirskis T, Heinimaa M et al. Substance abuse and related diagnoses in early psychosis. Comprehensive Psychiatry 2005; 46: 447-452.
9. Sorbara F, Liraud F, Assens F, Abalan F, Verdoux H. Substance use and the course of early psychosis: a 2-year follow-up of first-admitted subjects. European Psychiatry 2003; 18: 133-136.
10. Wade D, Harrigan S, Edwards J, Burgess PM, Whelan G, McGorry PD. Substance misuse in first-episode psychosis: 15-month prospective follow-up study. British Journal of Psychiatry 2006; 189: 229-234. (Pubitemid 44343467)
11. Boydell J, Dean K, Dutta R, Giouroukou E, Fearon P, Murray R. A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis. Schizophrenia Research 2007; 93: 203-210.
12. Grech A, Van Os J, Jones PB, Lewis SW, Murray RM. Cannabis use and outcome of recent onset psychosis. European Psychiatry 2005; 20: 349-353.
13. Veen N, Selten J-P, van der Tweel I, Feller WG, Hoek HW, Kahn RS. Cannabis use and age of onset of schizophrenia. American Journal of Psychiatry 2004; 161: 501-506.
14. Barnes TRE, Mutsatsa SH, Hutton SB, Watt HC, Joyce EM. Comorbid substance use and age at onset of schizophrenia. British Journal of Psychiatry 2006; 188: 237-242.
15. Pencer A, Addington J. Substance use and cognition in early psychosis. Journal of Psychiatry and Neuroscience 2003; 28: 48-54.
16. Sevy S, Robinson DG, Solloway S et al. Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder. Acta Psychiatrica Scandinavica 2001; 104: 367-374.
17. Stirling J, Lewis S, Hopkins R, White C. Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up. Schizophrenia Research 2005; 75: 135-137.
18. Hambrecht M, Hafner H. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective. Australian and New Zealand Journal of Psychiatry 2000; 34: 469-475.
19. Fergusson DM, Horwood LJ, Swain-Campbell NR. Cannabis dependence and psychotic symptoms in young people. Psychological Medicine 2003; 33: 15-21.
20. Verdoux H, Gindre C, Sorbara F, Tournier M, Swendsen JD. Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study. Psychological Medicine 2003; 33: 23-32.
21. Miller P, Lawrie SM, Hodges A, Clafferty R, Cosway R, Johnstone EC. Genetic liability, illicit drug use, life stress and psychotic symptoms: preliminary findings from the Edinburgh study of people at high risk for schizophrenia. Social Psychiatry and Psychiatric Epidemiology 2001; 36: 338-342.
22. Phillips LJ, Curry C, Yung AR, Yuen HP, Adlard S, McGorry PD. Cannabis use is not associated with the development of psychosis in an 'ultra' high risk group. Australian and New Zealand Journal of Psychiatry 2002; 36: 800-806.
23. Arseneault L, Cannon M, Witton J, Murray R. Causal association between cannabis and psychosis: examination of the evidence. British Journal of Psychiatry 2004; 184: 110-117. (Pubitemid 38186851)
24. Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G. Self-reported cannabis use as a risk factor for schizophrenia: further analysis of the 1969 Swedish conscript cohort. British Medical Journal 1002; 325: 1199-1201.
25. Van Os J, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux H. Cannabis use and psychosis: a longitudinal population-based study. American Journal of Epidemiology 2002; 156: 319-327.
26. Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. British Medical Journal 2002; 325: 1212-1213.
27. Caspi A, Moffitt TE, Cannon M et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-Omethyltransferase gene: longitudinal evidence of a gene X environment interaction. Biological Psychiatry 2005; 57: 1117-1127.
28. McKetin R, McLaren J, Lubman DI, Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction 2006; 101: 1473-1478.
29. Degenhardt L, Roxburgh A, Black E et al. The epidemiology of methamphetamine use and harm in Australia. Drug and Alcohol Review 2008; 27: 243-252.
30. Darke S, Kaye S, McKetin R, Duflou J. Major physical and psychological harms of methamphetamine use. Drug and Alcohol Review 2008; 27: 253-262.
31. Chen C-K, Lin S-K, Sham PC et al. Pre-morbid characteristics and comorbidity of methamphetamine users with and without psychosis. Psychological Medicine 2003; 33: 1407-1414.
32. Chen CK, Lin SK, Sham PC, Ball D, Loh el-W, Murray RM. Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis. American Journal of Medical Genetics 2005; 136: 87-91.
33. Addington J, Addington D. Effect of substance misuse in early psychosis. British Journal of Psychiatry 1998; 172 (Suppl. 33): 134-136.
34. Arendt M, Rosenberg R, Foldager L, Perto G, Munk-Jorgensen P. Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases. British Journal of Psychiatry 2005; 187: 510-515.
35. Addington J, Addington D. Impact of an early psychosis program on substance use. Psychiatric Rehabilitation Journal 2001; 25: 60-67.
36. Kavanagh DJ, Young R, White A et al. Start Over and Survive: a brief intervention for substance misuse in early psychosis. In: Graham HL, Copello A, Birchwood MJ, Mueser KT, eds. Substance Misuse in Psychosis: Approaches to Treatment and Service Delivery. Chichester: Wiley, 2003; 245-258.
37. Kavanagh DJ, Young R, White A et al. A brief motivational intervention for substance misuse in recent-onset psychosis. Drug and Alcohol Review 2004; 23: 151-155.
38. Kemp R, Harris A, Vurel E, Sitharthan T. Stop Using Stuff: trial of a drug and alcohol intervention for young people with comorbid mental illness and drug and alcohol problems. Australasian Psychiatry 2007; 15: 490-492.
39. Farrelly S, Harris MG, Henry LP et al. Prevalence and correlates of comorbidity 8 years after a first psychotic episode. Acta Psychiatrica Scandinavica 2007; 116: 62-70.
40. Edwards J, Hinton M, Elkins K, Athanasopoulos O. Cannabis and first-episode psychosis: the CAP Project. In: Graham HL, Copello A, Birchwood MJ, Mueser KT, eds. Substance Misuse in Psychosis: Approaches to Treatment and Service Delivery. Chichester: Wiley, 2003; 282-304.